Unfortunately, difficulty disentangling the fraction of NGAL elevation that is attributable to AKI, vs. a more generic systemic inflammatory response among patients with sepsis, likely limits its utility as a single biomarker for the diagnosis of SA-AKI, although more study is warranted. The gene discussed is LCN2; the disease is acute kidney injury.